Claudia Schlundt1,2, Christian H Bucher1,2, Serafeim Tsitsilonis1,2, Hanna Schell1, Georg N Duda3,4, Katharina Schmidt-Bleek1,2. 1. Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. 2. Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany. 3. Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. georg.duda@charite.de. 4. Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany. georg.duda@charite.de.
Abstract
PURPOSE OF REVIEW: Impaired healing outcomes or even non-unions after bone injury are still a highly relevant problem in the daily clinical life. Especially within an aging population, the occurrence of bone fractures increases and thus novel treatment approaches to overcome compromised bone regeneration are needed. RECENT FINDINGS: The gold standard to treat delayed or non-healing bone injuries is still the use of autologous bone grafts to foster regeneration. Besides its successful treatment outcome, it also has disadvantages: a second surgery is needed in order to harvest the bone material and the material is highly limited. Looking into the recent literature, a multitude of different research approaches were already conducted to identify new possible strategies to treat impaired bone regeneration: application of mesenchymal stromal cells, platelet lysates, growth factors, interference in the immune system, or bone formation stimulation by ultrasound. This review gives an overview of the treatment approaches actually performed in the clinic as well as at the bench in the context of compromised bone healing. It clearly highlights the complexity of the nature of non-healing bone fractures as well as patient-dependent factors influencing the healing process.
PURPOSE OF REVIEW: Impaired healing outcomes or even non-unions after bone injury are still a highly relevant problem in the daily clinical life. Especially within an aging population, the occurrence of bone fractures increases and thus novel treatment approaches to overcome compromised bone regeneration are needed. RECENT FINDINGS: The gold standard to treat delayed or non-healing bone injuries is still the use of autologous bone grafts to foster regeneration. Besides its successful treatment outcome, it also has disadvantages: a second surgery is needed in order to harvest the bone material and the material is highly limited. Looking into the recent literature, a multitude of different research approaches were already conducted to identify new possible strategies to treat impaired bone regeneration: application of mesenchymal stromal cells, platelet lysates, growth factors, interference in the immune system, or bone formation stimulation by ultrasound. This review gives an overview of the treatment approaches actually performed in the clinic as well as at the bench in the context of compromised bone healing. It clearly highlights the complexity of the nature of non-healing bone fractures as well as patient-dependent factors influencing the healing process.
Entities:
Keywords:
Autologous bone graft; Bone fracture healing; Cell therapy; Compromised healing; Immune therapy; Non-union
Authors: Britta Trepczik; Jasmin Lienau; Hanna Schell; Devakara R Epari; Mark S Thompson; Jan-Erik Hoffmann; Anke Kadow-Romacker; Stefan Mundlos; Georg N Duda Journal: Bone Date: 2006-11-30 Impact factor: 4.398
Authors: Jasmin Lienau; Hanna Schell; Georg N Duda; Petra Seebeck; Sarah Muchow; Hermann J Bail Journal: J Orthop Res Date: 2005-05 Impact factor: 3.494
Authors: Paula Kolar; Katharina Schmidt-Bleek; Hanna Schell; Timo Gaber; Daniel Toben; Gerhard Schmidmaier; Carsten Perka; Frank Buttgereit; Georg N Duda Journal: Tissue Eng Part B Rev Date: 2010-08 Impact factor: 6.389
Authors: Peter V Giannoudis; Nikolaos K Kanakaris; Rozalia Dimitriou; Ian Gill; Vinod Kolimarala; Richard J Montgomery Journal: Clin Orthop Relat Res Date: 2009-04-24 Impact factor: 4.176
Authors: Sofia Bougioukli; Morgan Chateau; Heidy Morales; Venus Vakhshori; Osamu Sugiyama; Daniel Oakes; Donald Longjohn; Paula Cannon; Jay R Lieberman Journal: Gene Ther Date: 2020-08-17 Impact factor: 5.250
Authors: A Polikarpova; A Ellinghaus; O Schmidt-Bleek; L Grosser; C H Bucher; G N Duda; E M Tanaka; K Schmidt-Bleek Journal: NPJ Regen Med Date: 2022-06-30
Authors: Connor P Dolan; Felisha Imholt; Tae-Jung Yang; Rihana Bokhari; Joshua Gregory; Mingquan Yan; Osama Qureshi; Katherine Zimmel; Kirby M Sherman; Alyssa Falck; Ling Yu; Eric Leininger; Regina Brunauer; Larry J Suva; Dana Gaddy; Lindsay A Dawson; Ken Muneoka Journal: J Bone Miner Res Date: 2021-12-07 Impact factor: 6.390
Authors: T Chevalley; M L Brandi; E Cavalier; N C Harvey; G Iolascon; C Cooper; D Hannouche; J-F Kaux; A Kurth; S Maggi; G Maier; K Papavasiliou; N Al-Daghri; M Sosa-Henríquez; N Suhm; U Tarantino; J-Y Reginster; R Rizzoli Journal: Osteoporos Int Date: 2021-05-20 Impact factor: 4.507